Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions  by Yamakawa, Hiroyuki et al.
Stem Cell Reports
ArticleFibroblast Growth Factors and Vascular Endothelial Growth Factor Promote
Cardiac Reprogramming under Defined Conditions
Hiroyuki Yamakawa,1 Naoto Muraoka,1 Kazutaka Miyamoto,1 Taketaro Sadahiro,1 Mari Isomi,1
Sho Haginiwa,1 Hidenori Kojima,1 Tomohiko Umei,1 Mizuha Akiyama,1 Yuki Kuishi,1 Junko Kurokawa,2
Tetsushi Furukawa,2 Keiichi Fukuda,1 and Masaki Ieda1,3,*
1Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan
2Department of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical Dental University, 1-5-45 Yushima, Bunkyo-ku,
Tokyo 113-8510, Japan
3JST, CREST, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
*Correspondence: mieda@z8.keio.jp
http://dx.doi.org/10.1016/j.stemcr.2015.10.019
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYFibroblasts can be directly reprogrammed into cardiomyocyte-like cells (iCMs) by overexpression of cardiac transcription factors,
including Gata4, Mef2c, and Tbx5; however, this process is inefficient under serum-based culture conditions, in which conversion of
partially reprogrammed cells into fully reprogrammed functional iCMs has been a major hurdle. Here, we report that a combination
of fibroblast growth factor (FGF) 2, FGF10, and vascular endothelial growth factor (VEGF), termed FFV, promoted cardiac reprogramming
under defined serum-free conditions, increasing spontaneously beating iCMs by 100-fold compared with those under conventional
serum-based conditions. Mechanistically, FFV activated multiple cardiac transcriptional regulators and converted partially reprog-
rammed cells into functional iCMs through the p38 mitogen-activated protein kinase and phosphoinositol 3-kinase/AKT pathways.
Moreover, FFV enabled cardiac reprogramming with only Mef2c and Tbx5 through the induction of cardiac reprogramming factors,
includingGata4. Thus, defined culture conditions promoted the quality of cardiac reprogramming, and this finding provides new insight
into the mechanism of cardiac reprogramming.INTRODUCTION
Direct reprogramming generates the desired cell types
from fibroblasts without passing through a stem cell
state by overexpression of tissue-specific transcription fac-
tors. Transduction with reprogramming factors rapidly
suppresses the fibroblast signature and concomitantly ac-
tivates the target cell program to generate partially reprog-
rammed cells, which become more fully reprogrammed
functional cells after prolonged cultivation (Sadahiro
et al., 2015; Vierbuchen and Wernig, 2012). We and
others reported the generation of cardiomyocyte-like cells
(iCMs) from fibroblasts using combinations of cardiac-
specific factors, including Gata4, Mef2c, and Tbx5 (GMT)
(Addis et al., 2013; Chen et al., 2012; Ieda et al., 2010;
Jayawardena et al., 2012; Protze et al., 2012; Song et al.,
2012). Transduction with GMT suppresses the expression
of fibroblast-related genes and activates a cardiac reporter,
aMHC promoter-driven GFP (aMHC-GFP), and cardiac
protein expression in 20% of fibroblasts after 1 week;
however, few cells (0.1% of the starting fibroblasts) are
fully reprogrammed into functional iCMs after 4 weeks
under conventional serum-based culture conditions, sug-
gesting that most aMHC-GFP+ cells remain partially re-
programmed or immature iCMs by the original method
(Ieda et al., 2010; Sadahiro et al., 2015). We and others
have reported that miR-133 and inhibition of pro-fibrotic1128 Stem Cell Reports j Vol. 5 j 1128–1142 j December 8, 2015 j ª2015 Thsignaling promote cardiac reprogramming by silencing
fibroblast signatures at the early stage of reprogramming;
however, the molecular mechanisms underlying the con-
version of partially reprogrammed cells into functional
iCMs at the later stage remain undetermined (Muraoka
et al., 2014; Zhao et al., 2015). Given that endogenous
cardiac fibroblasts can be converted into more fully re-
programmed functional iCMs by in vivo reprogramming,
undefined extrinsic factors may promote the quality of
cardiac reprogramming (Inagawa et al., 2012; Qian
et al., 2012; Song et al., 2012).
Recently, multiple groups showed that modification of
the reprogramming factors could promote cardiac reprog-
ramming (Sadahiro et al., 2015). Cahan et al. (2014)
analyzed the gene regulatory network of the aMHC-GFP+
population, in which a vast majority of the cells were
partially reprogrammed iCMs, using a network biology
platform, CellNet, that assesses the fidelity of engineered
cells (Morris et al., 2014). The aMHC-GFP+ cells were found
to be exclusively classified as cardiomyocytes; however,
multiple cardiac transcriptional regulators, including
Gata6, Hand2, and Nkx2.5, were incompletely activated
in the aMHC-GFP+ population, and supplementation of
these factors could improve cardiac reprogramming.
Indeed, addition of Hand2 to GMT (GHMT) increases gen-
eration of cells expressing cardiac proteins and spontane-
ously beating iCMs, and addition of Nkx2.5 to GMT ore Authors
Figure 1. FFV Promoted GMT-Induced Cardiac Functional Reprogramming
(A) Schematic representation of the strategy used to test candidate compounds in SF (red bar) compared with FBS (black bar). The number
of beating cells in each well was counted after 4 weeks.
(B and C) The number of spontaneously beating cells in each well after transduction of mock or GMT in MEFs. GMT-transduced cells were
cultured under the indicated conditions.
(D) The number of spontaneously beating cells in each well after transduction of mock or GMT in FBS, SF, or FFV.
(legend continued on next page)
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GHMT increases the number of iCMs exhibiting calcium
activity (Addis et al., 2013; Song et al., 2012). However, to
date, extrinsic factors that regulate expression of multiple
reprogramming factors have not been identified.
The use of undefined serum-containing medium has
been associated with considerable batch-to-batch variation
in cardiac reprogramming, leading to variable and low
reprogramming efficiency in previous studies (Chen
et al., 2012; Qian et al., 2013). Standardization of efficient,
reproducible, and defined culture conditions for cardiac re-
programming is needed. In contrast, cardiomyocytes can
be efficiently differentiated from pluripotent stem cells
(PSCs) under defined serum-free media containing com-
pounds that mimic the developmental signals in embryos
(Burridge et al., 2014; Kattman et al., 2011). It remains
unknown whether these cardiogenic compounds can pro-
mote cardiac reprogramming under defined culture condi-
tions and reduce the genetic manipulations required for
cardiac reprogramming.
Here, we screened eight cardiogenic compounds and
found that a combination of fibroblast growth factor
(FGF) 2, FGF10, and vascular endothelial growth factor
(VEGF), termed FFV, greatly improved the quality of cardiac
reprogramming inmouse fibroblasts under serum-free con-
ditions. FFV treatment activatedmultiple cardiac transcrip-
tional regulators and converted partially reprogrammed
iCMs into functional iCMs through the p38 mitogen-acti-
vated protein kinase (MAPK) and phosphoinositol 3-kinase
(PI3K)/AKT pathways. It also eliminated the need of Gata4
in cardiac reprogramming.RESULTS
FFV Promoted the Direct Reprogramming of
Fibroblasts into Functional iCMs under Defined
Conditions
We previously screened cardiac reprogramming factors by
analyzing the induction of cardiac reporter and protein
expression after 1 week; however, this method may not(E) Spontaneously beating GMT-iCMs in FBS or FFV after 4 weeks (a
Movie S2.
(F) The number of spontaneously beating cells in three independent
(G and H) Spontaneous Ca2+ oscillations in GMT-iCMs (arrowheads) af
and minimum concentrations of Ca2+ are shown in the upper panels, a
total number of Ca2+ oscillation+ cells in ten randomly selected fields p
also Figure S1D.
(I) Immunocytochemistry for aMHC-GFP, a-actinin, and DAPI. GMT-
insets show sarcomeric organization. See also Figure S1E.
All data are presented as mean ± SD. **p < 0.01 versus the relevant c
panels, and I) or 500 ms (G, lower panel).
See also Figure S1 and Movies S1, S2, and S3.
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tional iCMs. Thus, in this study, we analyzed cardiac
reprogramming efficiency by counting the number of
spontaneously contracting iCMs after 4 weeks. We tested
eight small molecules and growth factors involved in car-
diac differentiation from PSCs in serum-free StemPro-34
SF medium (SF) (Burridge et al., 2014; Kattman et al.,
2011). We used mouse embryonic fibroblasts (MEFs) from
aMHC-GFP transgenic mice to determine cardiac gene
expression in the beating cells. GMT-transduced MEFs
were cultured with DMEM/M199/10% fetal bovine serum
(FBS; the culture condition in the previous studies) or SF
with or without individual reagents for 4 weeks (Ieda
et al., 2010; Muraoka et al., 2014), and the number of
contracting iCMs was counted using an all-in-one fluores-
cence microscope system (Figure 1A). Addition of FGF2,
FGF10, or VEGF to SF resulted in a higher number of con-
tracting iCMs than that observed with SF alone or FBS,
while activin A, bone morphogenic protein (BMP) 4,
CHIR99021, Dickkopf-related protein 1 (DKK1), and trans-
forming growth factor (TGF)-b had no significant effects
(Figure 1B). Intriguingly, a combination of FGF2, FGF10,
and VEGF resulted in markedly improved cardiac reprog-
ramming compared to that observed with the addition of
only one or two growth factors in SF (Figures 1C, S1A,
and S1B). The uninfected MEFs did not contract, suggest-
ing that no starting MEFs contaminated the CM popula-
tion. GMT-transduced MEFs cultured with FFV started to
contract earlier, and a greater population of aMHC-GFP+
cells contracted in FFV-containing medium than in FBS
(Figures 1D, 1E, and S1C;Movies S1 and S2). FFV treatment
resulted in a markedly higher number of beating iCMs and
spontaneous Ca2+ oscillations compared to FBS, suggesting
that FFV increased the generation of functional iCMs (Fig-
ures 1F–1H and S1D; Movie S3). Addition of FFV to FBS did
not increase the reprogramming efficiency, suggesting
that the serum may contain inhibitory factors (Fig-
ure 1F). Immunostaining confirmed that the beating
iCMs in FFV expressed multiple cardiac markers, including
aMHC-GFP, a-actinin, cardiac troponin T (cTNT), and atrialrrowheads), corresponding to Movie S1. See also Figure S1C and
triplicate experiments is shown.
ter 4 weeks of FFV treatment, corresponding to Movie S3. Maximum
nd the Rhod-3 intensity trace is shown in the lower panel (G). The
er well is shown (n = 3 independent triplicate experiments) (H). See
iCMs expressed cardiac proteins, and high-magnification views in
ontrol. ns, not significant. Scale bars represent 100 mm (E, G upper
e Authors
Figure 2. FFV Promoted Cardiac Reprogramming by Functioning during the Late Phase
(A) GMT-transduced MEFs were cultured with either FBS (black bars, left) or FFV (red bars) as indicated for 4 weeks. The number of beating
cells in three independent triplicate experiments is shown (right).
(B and C) FACS analyses for aMHC-GFP and cTNT expression in GMT-transduced MEFs cultured with FBS or FFV for 1 week. Quantitative data
are shown in (C) (n = 3 independent triplicate experiments).
(legend continued on next page)
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natriuretic peptide (ANP), and had well-defined sarcomeric
structures (Figures 1I and S1E).
FFV Promoted Cardiac Reprogramming by Converting
Partially Reprogrammed Cells into Functional iCMs
Next, we analyzed the time during which FFV plays a crit-
ical role in the generation of functional iCMs by changing
the culture medium sequentially after GMT infection.
Treatment with FFV for the last 2 weeks was sufficient to
enhance cardiac reprogramming, while FFV treatment
for the first 1 week did not affect reprogramming, suggest-
ing that FFV was critical for the late but not early stage of
reprogramming (Figure 2A). Consistent with this, fluores-
cence-activated cell sorting (FACS) analyses demonstrated
that induction of aMHC-GFP and cTNT expression was
not altered in the FFV-containing medium after 1 week,
indicating FFV did not increase the generation of partially
reprogrammed iCMs (Figures 2B and 2C). There are
several possibilities for the increase in the numbers of
spontaneously beating iCMs, without the generation of
partially reprogrammed iCMs, caused by the addition
of FFV—induction of mitotic cardiac progenitor cells
(CPCs), stimulation of iCM proliferation, and generation
of pacemaker type cardiomyocytes. The lineage-tracing
experiments performed using Mesp1-Cre/GFP mice
demonstrated that iCM generation was not mediated
through Mesp1-expressing CPCs in either FFV or FBS (Fig-
ures S2A and S2B). Moreover, Mesp1 and the later CPC
marker, isl1, were not expressed in the starting MEFs or
the GMT-transduced cells, suggesting that the CPCs
were not contaminated or induced during the reprogram-
ming process (Figures 2D and 2E). Next, we performed
EdU incorporation assays to determine the cell prolifera-
tion status. A 2-week pulse labeling of EdU at the late
stage of reprogramming, during which FFV increased the
number of functional iCMs, demonstrated that a vast ma-
jority of iCMs did not express EdU (Figures 2F–2H).(D) qRT-PCR for Mesp1 and isl1 expression in GMT-transduced cells cu
(E) qRT-PCR for Mesp1, isl1, Tnnt2, and Tnni3 expression in MEFs, iCM
experiments). The iCMs expressed cardiac genes, but not CPC genes.
(F) Schematic representation of EdU treatment during cardiac reprog
(G) FACS analysis of EdU incorporation in mock-transduced cells an
transduction.
(H) Immunocytochemistry for cTNT in mock-transduced and GMT-tra
2 weeks of EdU incorporation. The majority of immunopositive cells w
(I) Quantitative data of immunopositive cells for HCN4, MLC2a, and ML
triplicate experiments).
(J) GMT-transduced cells were cultured with FBS for 1 week and then s
per well on 24-well plates is shown (right, n = 3 independent triplica
(K) GMT-transduced cells were cultured with FBS for 2 weeks, and th
beating cells after 4 weeks is shown (n = 3 independent triplicate ex
All data are presented as mean ± SD. **p < 0.01; *p < 0.05 versus the
See also Figure S2.
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GFP+ cells, and cTNT+ cells did not increase with FFV
treatment after 4 weeks, suggesting that FFV did not stim-
ulate cell proliferation (Figures S2C–S2E). qRT-PCR and
immunostaining for sinoatrial nodal, atrial, and ven-
tricular myocytes revealed that the proportion of HCN4+
pacemaker cells did not increase with FFV (Figures 2I
and S2F–S2I). These results suggested that FFV increased
the number of beating iCMs by functioning at the late
stage of reprogramming; however, this effect was not
due to the generation of partially reprogrammed iCMs
or mitotic CPCs, proliferation of iCMs, or induction of
pacemaker cells.
Our observation that FFV increased the ratio of beating
iCMs/aMHC-GFP+ cells suggested that FFV may promote
the conversion of partially reprogrammed iCMs into func-
tional iCMs. To test this, after culturing GMT-transduced
MEFs with FBS for 1 week, at which point the cells re-
mained in a partially reprogrammed state, we split them
into FBS or FFV groups and cultured the cells for an addi-
tional 3 weeks. The number of beating iCMs was signifi-
cantly increased with FFV, and the cardiac reprogramming
efficiency was further increased with the addition of IWP4,
an inhibitor of Wnt signaling, to the FFV-containing
medium; the reprogramming efficiency increased by
approximately 100-fold compared to that observed in the
conventional FBS condition (Figures 2J and 2K). Therefore,
FFV improved the quality of cardiac reprogramming by
enhancing the conversion of partially reprogrammed cells
into functional iCMs.
FFV Increased the Expression of Multiple Cardiac
Transcriptional Regulators through p38MAPK and
PI3K/AKT Pathways
Next, we studied the gene expression profiles of the iCMs
cultured with FBS, SF alone, or FFV by microarray
analyses. We isolated the aMHC-GFP+ cells using FACSltured with FBS or FFV (n = 3 independent triplicate experiments).
s, mouse ES-derived CPCs, and hearts (n = 3 independent triplicate
ramming.
d GMT-transduced MEFs cultured with FBS or FFV after 4 weeks of
nsduced MEFs cultured with FBS or FFV for 4 weeks, coupled with
ere negative for EdU in the iCMs.
C2v in iCMs cultured with FBS or FFV for 4 weeks (n = 7 independent
plit into either FBS or FFV groups (left). The number of beating cells
te experiments).
e media were changed to FFV or IFFV (FFV + IWP4). The number of
periments).
relevant control. ns, not significant. Scale bars represent 100 mm.
e Authors
Figure 3. FFV Promoted Cardiac Reprogramming via the Activation of Cardiac Transcriptional Regulators
(A) Heatmap images of microarray data illustrating the global gene expression patterns of MEFs, iCMs cultured under the indicated
conditions, and the hearts. The iCMs were sorted as aMHC-GFP+ cells at 2 and 4 weeks after GMT transduction. Differentially expressed
genes between MEFs and the hearts are shown.
(B and C) Differentially expressed genes between iCMs cultured with FFV and those cultured with FBS or SF are shown (B). From this
analysis, it was found that 306 and 548 genes were upregulated in iCMs cultured with FFV for 2 and 4 weeks, respectively, while 245 and 271
genes were downregulated after 2 and 4 weeks, respectively (C).
(legend continued on next page)
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at 2 and 4 weeks after GMT transduction, before and after
the cells started contraction, and identified the differen-
tially expressed genes between MEFs and the hearts. The
heatmap image revealed a shift in the global gene expres-
sion patterns of iCMs from a MEF state toward a cardiac
state after 2 and 4 weeks for all culture conditions (Fig-
ure 3A). Next, to determine the mechanisms responsible
for the effect of FFV on cardiac reprogramming, we exam-
ined the differentially expressed genes in iCMs cultured
with FFV compared with those in cells cultured with FBS
or SF. FFV upregulated 306 and 548 genes after 2 and
4 weeks, respectively, but did not alter the number of
downregulated genes (Figures 3B and 3C). Consistent
with the occurrence of functional reprogramming after
4 weeks, genes that were upregulated following treatment
with FFV at 4 weeks were enriched for gene ontology (GO)
terms associated with heart development and cardiac
functional properties (Figure 3D). Heatmap images and
qRT-PCR analyses revealed that FFV upregulated a panel
of cardiac genes related to different functions, including
transcription factors (Gata6, Hand2, Nkx2.5, Hey2,
Ppargc1a, Smyd1, Sirt3, and Srf), sarcomeric structures,
and ion channels (Figures 3E, 3F, and S3A). The upregu-
lated transcription factors were cardiac reprogramming
factors or candidate factors that have been found to
enhance cardiac reprogramming in previous studies and
CellNet analyses (Figures 3E and S3A) (Addis et al.,
2013; Cahan et al., 2014; Christoforou et al., 2013; Song
et al., 2012). In contrast, fibroblast gene expression
(Col1a1 and Snai1) was not significantly altered by FFV
treatment (Figure S3B), suggesting that FFV promoted car-
diac reprogramming by activating cardiac programming
rather than suppressing fibroblast signatures, which is
consistent with the observation that FFV functioned at
the late stages of reprogramming.
FGF and VEGF activate MAPK and PI3K/AKT pathways.
To investigate the signaling pathways involved in FFV-
mediated cardiac reprogramming by GMT, we analyzed
the activation of MAPK and AKT. Western blot analyses(D) GO analyses of the upregulated genes in GMT-iCMs treated with F
(E) Heatmap image of the expression of cardiomyocyte-enriched genes
(black letters), and ion channels (blue letters), in the iCMs cultured
(F) GMT-transduced cells were cultured with SF (black bars), FFV wit
LY294002 (yellow bars). Relative mRNA expression was determined by
Data were normalized to the values of GMT-transduced cells in SF. Se
(G) Western blot analyses for p-ERK, p-p38MAPK p-AKT, total ERK, t
cultured with or without FFV.
(H) GMT-transduced cells were cultured with FBS for 2 weeks, and th
number of beating cells after 4 weeks is shown (n = 3 independent tr
All data are presented as mean ± SD. **p < 0.01; *p < 0.05 versus the re
LY294002. The scales are –0.5 to +0.5 in log10 (A) and 1 to +1 in l
See also Figure S3.
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pho-p38MAPK, and phospho-AKT was strongly induced
by FFV treatment (Figure 3G). To identify the pathways
involved in cardiac functional reprogramming, the GMT-
transduced cells were cultured with FFV with or without
specific inhibitors of these pathways during the late stage
of reprogramming.We found that SB203580 (p38MAPK in-
hibitor) and LY294002 (PI3K inhibitor), but not PD98059
(MEK inhibitor), reduced the generation of beating iCMs,
suggesting that FFV improved cardiac reprogramming
through p38MAPK and PI3K/AKT, but not through MEK/
ERK1/2 (Figure 3H). qRT-PCR analyses revealed that the
key cardiac transcriptional regulators and a panel of cardiac
genes were also suppressed by SB203580 and LY294002,
suggesting that FFV activated the cardiac transcriptional
profile via p38MAPK and PI3K/AKT pathways (Figure 3F).
FFV Enabled the Direct Reprogramming of Fibroblasts
into Functional iCMs withMef2c and Tbx5
Next, we investigated whether FFV could generate func-
tional iCMs with fewer reprogramming factors. A com-
bination of two factors, Mef2c and Tbx5 (MT), induced
functional iCMs under FFV culture (Figures 4A and 4B).
In contrast, different two-factor combinations or the appli-
cation of one factor alone did not induce the generation of
beating iCMs. The efficiency of induction of functional
iCMs with MT and FFV was similar to that with GMT and
FBS, suggesting that FFV replaced the need for Gata4.
qRT-PCR revealed that FFV upregulated the expression of
cardiac reprogramming factors, such as Gata4, Hand2,
and Nkx2.5 (Figure 4C). Morphologically, the MT-iCMs in
FFV appeared thicker and more refractive than MEFs,
with a polygonal or rod-like shape (Figure 4D; Movie S4).
Moreover, the MT-iCMs demonstrated spontaneous Ca2+
oscillations, expressed several cardiac markers, including
aMHC-GFP, a-actinin, and cTNT, and had well-defined
sarcomeric structures, suggesting that they are cardiac my-
ocytes (Figures 4E–4I). However, the efficiency of cardiac re-
programming byMTwith FFV was significantly lower thanFV for 4 weeks. Cardiac-related GO terms are shown.
, related to transcription factors (red letters), sarcomeric structures
with FBS and FFV.
hout inhibitors (red bars), and FFV with SB203580 (green bars) or
qRT-PCR after 4 weeks (n = 3 independent triplicate experiments).
e also Figures S3A and S3B.
otal p38MAPK, and total AKT expression in GMT-transduced MEFs
e media were changed to SF or FFV with or without inhibitors. The
iplicate experiments).
levant control. ns, not significant; PD, PD98059; SB, SB203580; LY,
og10 (B and E).
e Authors
Figure 4. Mef2c and Tbx5 Converted Fibroblasts into Functional iCMs under Defined Conditions
(A) The number of beating cells after transduction with GMT, one single factor, or combinations of two factors in FFV or FBS medium (n = 3
independent triplicate experiments). G, Gata4; M, Mef2c; T, Tbx5.
(B) The number of beating cells after transduction of MT in FBS or FFV (n = 3 independent triplicate experiments).
(C) Relative mRNA expression of Gata4, Hand2, and Nkx2.5 in MEFs and MT-iCMs cultured with FBS or FFV were determined by qRT-PCR (n = 3
independent triplicate experiments). Data were normalized against the values in MEFs.
(legend continued on next page)
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that of GMT with FFV, suggesting that Gata4, while
dispensable, played an important role in cardiac reprog-
ramming (Figures 1I, 4A, 4H, 4I, and S1E). The heatmap im-
age and scatter-plot analyses demonstrated that the global
gene expression profile of MT-iCMs changed from that
similar to the gene expression profile of fibroblasts toward
that of cardiac cells (Figures 4J and 4K). qRT-PCR and array
data confirmed that a panel of cardiac genes was higher,
while fibroblast gene expression was lower in MT-iCMs
than in MEFs (Figures 4L and 4M). Importantly, the
MT-iCMs did not express genes of other muscle cells,
such as the skeletal muscle or smoothmuscle cells, suggest-
ing that they were cardiac-specific myocytes (Figure 4M).
These results indicated that FFVupregulated the expression
of multiple cardiac reprogramming factors, including
Gata4, and enabled cardiac reprogramming with only
Mef2c and Tbx5.
FFV Promoted Cardiac Reprogramming in Postnatal
Tail-Tip Fibroblasts
Next, to test the universality of the effect of FFV on cardiac
induction by other reprogramming factors, we investigated
whether FFV could promote cardiac reprogramming by
GHMT. GHMT generated more functional iCMs than
GMT alone in FBS, and this effect was enhanced following
treatment with FFV (Figure 5A). Interestingly, GHMT-iCMs
sometimes beat synchronously, similar to contractile cell
sheets, when treated with FFV (Figure S4A; Movie S5).
FACS analyses demonstrated that GHMT generated more
cTNT+ cells than GMT after 1 week, suggesting that
Hand2 promoted cardiac reprogramming, at least in part,
by functioning at the early stage of reprogramming. Im-
munocytochemistry analysis confirmed that GHMT-iCMs
expressed cardiac proteins and had sarcomeric structures
(Figures S4B–S4D). To determine whether FFV treat-
ment played a role at the late stage of reprogramming by(D) MEFs and MT-induced beating iCMs (arrowhead), corresponding t
(E) The number of Ca2+ oscillation+ cells in ten randomly selected fie
(F and G) FACS analyses of aMHC-GFP+ and cTNT+ cells 1 week after M
(n = 3 independent triplicate experiments).
(H and I) Immunocytochemistry analysis of aMHC-GFP, a-actinin, cT
expression. The high-magnification views in the insets show sarcom
pendent triplicate experiments). See also Figures 1I and S1E.
(J) Heatmap images of microarray data for MEFs, MT- and GMT-iCMs, an
Differentially expressed genes between MEFs and hearts are shown.
(K) Scatter plots of gene expression changes in MT-iCMs compared w
(L) Relative mRNA expression levels of target genes in MEFs, MT-iCM
triplicate experiments). Data were normalized against the values in M
Myh7, Tnni3, Gja1, and Ppargc1a expression.
(M) The relative expression of cardiomyocyte (CM), skeletal muscle (S
those in MEFs, as determined by microarray analysis.
Data are presented as mean ± SD (D, F, and H). **p < 0.01; *p < 0.05
See also Movie S4.
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transduction (Figure 5B). The cardiac reprogramming effi-
ciency was further increased up to 9% (4628 beating
iCMs out of 50,000 starting fibroblasts), suggesting that
FFV promoted GHMT-mediated cardiac reprogramming at
the late stage of reprogramming, which is consistent with
the results of GMT-mediated reprogramming.
Next, to determine the cardiac reprogramming from
other type of fibroblasts and to exclude the possibility of
contamination of rare CPCs in the starting MEFs, we trans-
ducedmouse postnatal tail-tip fibroblasts (TTFs) withGMT,
GHMT, or GMT plus Mesp1 and Myocd (GMTMM), and
cultured the cells with FBS or FFV for 8 weeks (Figure 5C)
(Wada et al., 2013). Although GMT transduction did not
generate beating iCMs in FBS, FFV treatment induced the
generation of a small number of functional iCMs. GHMT
transduction with FFV increased the number of beating
cells, which was further increased with GMTMM. The
numbers of beating iCMs and spontaneous Ca2+ oscilla-
tions in the GMTMM-transduced TTFs were significantly
higher with FFV than with FBS (Figures 5C–5E; Movie
S6). The GMTMM-iCMs expressed several cardiac markers
and had well-defined sarcomeric structures under FFV (Fig-
ure 5F). FFV did not increase the generation of partially
reprogrammed iCMs, as shown by FACS (Figures 5G).
Microarray analyses revealed that FFV resulted in higher
expression of 1,461 genes and lower expression of 801
genes compared to the gene expression observed with
FBS treatment. GO terms related to cardiac function and
heart developmentwere highly associatedwith the upregu-
lated genes, but not with the downregulated genes, sug-
gesting that FFV globally activated cardiac programming
in TTFs (Figures 5H and S4E). qRT-PCR confirmed that
FFV upregulated a panel of cardiac genes, including
Gata6, Hand2, and Nkx2.5, without changing fibroblast
gene expression (Figure 5I).o Movie S4.
lds per well (n = 3 independent triplicate experiments).
T or GMT transduction with FFV. Quantitative data are shown in (G)
NT, and DAPI staining. MT induced aMHC-GFP and cardiac protein
eric organization. Quantitative data are shown in (I) (n = 5 inde-
d the hearts. The iCMs were sorted as aMHC-GFP+ cells after 4 weeks.
ith that in MEFs.
s, and the heart were determined by qRT-PCR (n = 3 independent
EFs. All data are presented as means, and the scales are log10 for
kM), and smooth muscle cell (SMC) genes in MT-iCMs compared to
versus the relevant control.
e Authors
Figure 5. FFV Promoted Cardiac Reprogramming by GMTMM in Postnatal TTFs
(A) The number of beating cells after transduction with GMT or GHMT in MEFs after culture with FBS or FFV for 4 weeks (n = 3 independent
triplicate experiments). See also Figure S4A and Movie S5.
(B) GHMT-transduced cells were cultured with FBS for 2 weeks and FFV for an additional 2 weeks (left). Cardiac reprogramming efficiency
was calculated as the number of beating cells divided by the number of starting fibroblasts (right).
(legend continued on next page)
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DISCUSSION
Here, we identified the defined culture conditions that
greatly promoted the quality of cardiac reprogramming.
We also determined the molecules and signaling pathways
critical in the late stage of cardiac reprogramming, which
has been a major hurdle for successful reprogramming.
Use of the defined condition could allow for the standard-
ization of the cardiac reprogramming protocol and provide
new insights into the mechanisms of cardiac reprogram-
ming. Our work showed that cardiac reprogramming is
not merely a nuclear event, but rather that it is determined
by the fine cross talk between intrinsic and extrinsic
factors.
We revealed that the cardiac reprogramming process can
be divided into early and late stages with distinctmolecular
features, and that the factors enhancing cardiac reprogram-
mingmay function at different stages. Consistent with pre-
vious reports, we found that the addition ofHand2 to GMT
increased the generation of spontaneously contracting
iCMs, at least in part, by promoting the generation of cells
expressing sarcomeric genes during early reprogramming
(Addis et al., 2013; Song et al., 2012). In contrast, FFV pro-
moted cardiac reprogramming by converting partially re-
programmed iCMs into functional iCMs at the late stage
of reprogramming, without increasing the numbers of
partially reprogrammed cells or cell proliferation. Thus,
the addition of Hand2 and FFV to GMT functioned at
both the early and late stages of reprogramming and syner-
gistically increased the cardiac reprogramming efficiency
in this study.
For directed cardiac differentiation from PSCs, Activin-
Nodal, BMP, and Wnt activation cause PSCs to commit to
the CPC fate, and subsequent inhibition of Wnt signaling
induces cardiac differentiation (Burridge et al., 2014). Katt-
man et al. (2011) used FGF and VEGF for cardiac differ-
entiation, but the effects of these growth factors on cardiac(C) The number of beating cells in each well after transduction with G
(n = 3 independent triplicate experiments).
(D) Spontaneously beating GMTMM-iCMs cultured with FFV for 8 weeks
postnatal TTFs.
(E) The total number of Ca2+ oscillation+ cells in ten randomly select
(F) Immunocytochemistry analysis for aMHC-GFP, a-actinin, cTNT, AN
protein expression in TTFs after 8 weeks. Insets are high-magnificati
(G) FACS analysis of aMHC-GFP and cTNT expression in GMTMM-TTFs
experiments).
(H) Heatmap image of microarray data for differentially expressed g
analysis, 1,461 genes were upregulated and 801 genes were downre
terms, including ‘‘heart’’ or ‘‘cardiac,’’ in the differentially expressed g
(I) mRNA expression patterns of TTFs and GMTMM-iCMs cultured in m
independent triplicate experiments). Data were normalized to the va
All data are presented as mean ± SD. **p < 0.01; *p < 0.05 versus th
See also Figure S4 and Movies S5 and S6.
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undetermined. We found that Activin, BMP, and Wnt
signaling activators did not promote cardiac reprogram-
ming, while FFV activated multiple cardiac transcriptional
regulators and increased the generation of functional
iCMs through the p38MAPK and PI3K/AKT pathways.
FFV-induced Gata6, Hand2, and Ppargc1a expression was
inhibited by pretreatmentwith either p38MAPKor PI3K in-
hibitor, while the expression of Nkx2.5 was largely medi-
ated through the PI3K/AKT pathway. In agreement with
this, the expression of Nkx2.5 was regulated by PI3K/AKT
activities in the cardiac differentiation of PSCs, suggesting
a link between themechanisms of iCMmaturation and car-
diac differentiation of PSCs (Naito et al., 2003; Roggia et al.,
2007). Consistent with our results, Zhou et al. (2015)
recently reported that addition of AKT1 to GHMT greatly
enhanced cardiac reprogramming through pathways
involving themitochondrial target of rapamycin complex1
(mTORC1) and forkhead box o3 (Foxo3). While we found
that the p38MAPK and PI3K/AKT pathways were critical
for cardiac reprogramming, there are many other pathways
involved in FFV signaling. Identification of such pathways
could enhance our understanding of the molecular mech-
anism underlying cardiac reprogramming and promote re-
programming efficiency.
We also found that FFV enabled cardiac reprogramming
with only Mef2c and Tbx5 through the induction of
Gata4 and other reprogramming factors. Recently, Baeyens
et al. (2014) reported that the transient administration of
two growth factors, epidermal growth factor and ciliary
neurotrophic factor, into adult diabetic mice efficiently
converted pancreatic exocrine cells into functional b-cells,
and ameliorated hyperglycemia without geneticmanipula-
tion in vivo. This effect was mediated through the induc-
tion of the expression of Neurogenin 3, which is one of
the reprogramming factors for b-cells. Given that the
in vivo environment might be more permissive thanMT, GHMT, or GMTMM in TTFs cultured with FBS or FFV for 8 weeks
(arrowheads), corresponding to Movie S6. The iCMs originated from
ed fields per well (n = 3 independent triplicate experiments).
P, and DAPI. GMTMM transduction induced aMHC-GFP and cardiac
on views.
cultured with FBS or FFV for 1 week (n = 3 independent triplicate
enes between GMTMM-iCMs cultured with FBS and FFV. From this
gulated in GMTMM-iCMs treated with FFV (left). The number of GO
enes is shown (right). See also Figure S4E.
edium containing FBS or FFV were determined by qRT-PCR (n = 3
lues of GMTMM-iCMs cultured in FBS.
e relevant control. ns, not significant.
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culture dishes for reprogramming, FFV with fewer reprog-
ramming factors might be sufficient to repair damaged
hearts by in vivo reprogramming. In agreement with this,
in vivo cardiac reprogramming by GMT with VEGF ad-
ministration enhanced the efficacy of GMT-mediated
functional recovery in mice after myocardial infarction
(Mathison et al., 2012). Further in vitro studies in human
cells and in vivo experiments in larger animals are needed
to apply this strategy to regenerative therapies. Neverthe-
less, we believe that our defined culture conditions could
serve as a powerful platform that can be used to identify
new compounds that enhance cardiac reprogramming
and reduce genetic manipulation, which would be highly
desirable for the development of pharmacological cardiac
regeneration.EXPERIMENTAL PROCEDURES
Generation of aMHC-GFP andMesp1-GFPMice
The Keio University Ethics Committee for Animal Experiments
approved all experiments in this study. Transgenic mice over-
expressing GFP under the aMHC promoter were generated as
described previously (Ieda et al., 2010). Mesp1-GFP mice were
obtained by crossing Mesp1-Cre mice and CAG-CAT-EGFP re-
porter mice (Ieda et al., 2010; Kawamoto et al., 2000; Saga
et al., 1999).
qRT-PCR
Total RNAwas isolated from the cells, and qRT-PCR was performed
using the StepOnePlus Real-Time PCR system with the following
TaqMan probes (Applied Biosystems): Actn2 (Mm00473657_m1),
Atp2a2 (Mm01201431_m1), Col1a1 (Mm00801666_g1), Col3a1
(Mm01254476_m1), Gja1 (Mm00439105_m1), Hcn4
(Mm01176086_m1), isl1 (Mm00517585_m1), Kcnq1
(Mm00434640_m1), Mesp1 (Mm00801883_g1), Myh6
(Mm00440354_m1), Myh7 (Mm01319006_g1), Myl2
(Mm00440384_m1), Myl7 (Mm01183005_g1), Nppa
(Mm01255747_g1), Ppargc1 (Mm01208835_m1), Ryr2
(Mm00465877_m1), Slc8a1 (Mm01232254_m1), Snai1
(Mm00441533_g1), Smyd1 (Mm00477663_m1), Tnnt2
(Mm00441922_m1), and Tnni3 (Mm00437164_m1). mRNA levels
were normalized to those of Gapdh (Mm99999915_g1).
Fibroblast Isolation
For MEF isolation, embryos isolated from 12.5-day pregnant mice
were washed with PBS, followed by the careful removal of head
and visceral tissues (Muraoka et al., 2014). The remaining parts
of the embryos were washed in fresh PBS, minced using a pair of
scissors, transferred to a 0.125% trypsin/EDTA solution (GIBCO,
25200-072; 3 ml per embryo), and incubated at 37C for 20 min.
An additional 3 ml of trypsin/EDTA solution was then added,
and the mixture was further incubated at 37C for 20 min. After
trypsinization, an equal amount of medium (6 ml of DMEM con-
taining 10% FBS per embryo) was added and pipetted several times
to allow tissue dissociation. After incubation of the tissue/mediumStem Cell Repmixture for 5 min at room temperature, the supernatant was tra-
nsferred to a fresh tube, and cells were collected by centrifugation
and resuspended in DMEM/10% FBS (Thermo Scientific,
SV30014.03) for culturing at 37C in 5% CO2. For TTF isolation,
tails of aMHC-GFP TG mice were minced into pieces smaller
than 1mm3 in size (Muraoka et al., 2014). The explantswere plated
on gelatin-coated dishes and cultured for 10–14 days in explant
medium (IMDM with L-glutamate and 25 mM HEPES [GIBCO,
12440-053]/20% FBS). Fibroblasts that migrated were harvested
and filtered with 40-mm cell strainers (BD Biosciences) to avoid
contamination with tissue fragments. The cells were plated at a
density of 1 3 104 cells/cm2 for retrovirus transduction. For all
experiments, fibroblasts at early passage numbers (P1–P3) were
used.Retroviral Infection and Cell Culture
To construct the pMXs retroviral vectors, we amplified the cod-
ing regions of GFP, Gata4, Mef2c, Tbx5, Hand2, Myocd, and
Mesp1 by PCR and subcloned them into respective pMXs vectors
for transfection into Plat-E cells using Fugene 6 (Promega, E2691)
to generate retroviruses (Ieda et al., 2010). Fibroblasts were trans-
duced with the retrovirus mixture as indicated. The medium was
replaced with FBS or FFV after 24 hr of infection and at the in-
dicated time points in some experiments. FBS medium con-
tained DMEM (high glucose) with L-glutamate and phenol red
(Wako, 044-29765), Medium199 with Earle’s salts, L-glutamate,
and 22 g/l sodium bicarbonate (GIBCO, 11150-059), and 10%
HyClone Characterized FBS (Thermo Scientific, SV30014.03).
FFV medium contained StemPro-34 SF medium (GIBCO,
10639-011), GlutaMAX (10 ml/ml, GIBCO, 35050-061), ascorbic
acid (50 mg/ml, Sigma Aldrich, A-4544), recombinant human
VEGF165 (5 ng/ml, R&D Systems, 293-VE-050), recombinant
human FGF basic146 aa (10 ng/ml, R&D Systems, 233-FB-025),
and recombinant human FGF10 (50 ng/ml, R&D Systems,
345-FG-025). Unless otherwise stated, the cells were cultured
in SF (StemPro-34 SF medium/GlutaMAX/ascorbic acid) su-
pplemented with or without recombinant human/mouse/rat
activin A (5 ng/ml, R&D Systems, 338-AC), recombinant hu-
man BMP4 (20 ng/mL, R&D Systems, 314-BP), CHIR99021
(3 mM, Selleck, S2924), recombinant human DKK1 (50 ng/ml,
R&D Systems, 5439-DK/CF), FGF2, FGF10, recombinant human
TGF-b (2 ng/ml, PeproTech, 100-21C), VEGF, and IWP4 (5 mM,
STEMGENT, 04-0036). PD98059 (5 mM), SB203580 (5 mM), or
LY294002 (10 mM, Calbiochem) was added after 2 weeks of cul-
ture in some experiments (Ieda et al., 2009). The medium was
changed every 3 days.FACS Analyses and Sorting
For aMHC-GFP/cTNTexpression, cells were fixed with 4% parafor-
maldehyde (PFA; MUTO PURE CHEMICALS, 3311-1) for 15 min,
permeabilized with saponin (Sigma Aldrich, 47036-250G-F),
stained with anti-cTNT (Thermo Scientific, MS-295-P1) and anti-
GFP (MBL, 598) antibodies, followed by secondary antibodies
conjugatedwith Alexa Fluor 488 (Invitrogen, A11008) and 647 (In-
vitrogen, A21240), respectively. Cells were then analyzed using a
FACS Calibur instrument (BD Biosciences) with the FlowJo soft-
ware (Tomy Digital Biology). For iCM sorting, cells were sortedorts j Vol. 5 j 1128–1142 j December 8, 2015 j ª2015 The Authors 1139
as aMHC-GFP + cells, and for Mesp1-GFP/Thy1+ cell sorting,
cells were incubated with APC-conjugated anti-THY1 antibodies
(eBioscience, 17-0909-41) and sorted using a FACS Aria III
instrument (BD Biosciences). Negative controls used for FACS
gating were based on the cells stained with isotype control
antibodies.
EdU Labeling Assay
For assessing cell proliferation, 10 mMEdUwas added to the culture
medium after 2 weeks of transduction andmaintained throughout
the culture for an additional 2 weeks. Cells were fixed with 4% PFA
for 15 min, permeabilized, and incubated with anti-cTNT
antibodies. Cells were then incubated with secondary antibodies
conjugated with Alexa Fluor 546 (for immunocytochemistry) or
647 (for FACS) and then incubated with the EdU reaction cocktail
following the manufacturer’s instructions (Click-iT EdU Alexa
Fluor 488 HCS Assay; Invitrogen, C10350).
Immunocytochemistry
Cells were fixed in 4% PFA for 15 min at room temperature,
blocked with 5% Normal Goat Serum blocking solution (Vector
Laboratories, S-1000), and incubated with primary antibodies
against atrial natriuretic peptide (ANP; Millipore, AB5490), cTNT
(Thermo Scientific, MS-295-P1), cTNI (Abcam, ab47003), GFP
(MBL, 598), MLC-2A (Synaptic Systems, 311-011), MLC-2V (Syn-
aptic Systems, 310-111), or sarcomeric a-actinin (Sigma Aldrich,
111M4845). Cells were then incubated with secondary antibodies
conjugated with Alexa Fluor 488 or 546, followed by DAPI (In-
vitrogen, D1306) counterstaining. The percentage of cells immu-
nopositive for GFP, a-actinin, cTNT, and ANP were counted in
10–15 randomly selected fields per well in at least three indepen-
dent experiments, and 2,000–4,000 cells were counted in total.
The measurements and calculations were conducted in a blinded
manner.
Western Blot Analysis
Lysates were prepared by homogenization of cells in RIPA buffer
and run on SDS-PAGE to separate proteins prior to the immuno-
blot analyses as described previously (Muraoka et al., 2014). After
transfer to nitrocellulose membranes, immunodetection was per-
formed using antibodies specific to p-ERK(Cell Signaling Technol-
ogy, 9101S), p-p38MAPK(Cell Signaling Technology, 9211S),
p-AKT(Cell Signaling Technology, 9271S), ERK(Cell Signaling
Technology, 9102S), p38MAPK(Cell Signaling Technology,
9212S), and AKT(Cell Signaling Technology, 9272S), followed by
the HRP-conjugated anti-rabbit immunoglobulin G secondary
antibody (Cell Signaling Technology, 7074S). The antibody-bound
proteins were visualized by chemiluminescence detection (ECL,
Amersham).
Ca2+ Imaging and Counting Beating Cells
Ca2+ imaging was performed following standard protocols. Briefly,
cells were labeled with Rhod-3 from a Calcium Imaging Kit (Invi-
trogen, R10145) for 1 hr at room temperature, washed, and incu-
bated for an additional hour, to allow de-esterification of the dye.
Rhod-3-labeled cells were analyzed at 37C using an LSM 510
META confocal microscope (Carl Zeiss). Ca2+ oscillations could1140 Stem Cell Reports j Vol. 5 j 1128–1142 j December 8, 2015 j ª2015 Thonly be imaged for a short period, owing to the increasing back-
ground fluorescence from the medium; thus, the measurements
were taken within 30 min after changing to Tyrode’s buffer. Ca2+
oscillation+ cells were counted in ten randomly selected fields
per well in at least three independent experiments, and a mini-
mum of 1,000 cells were counted.
To count the number of beating cells, we seeded 50,000 fibro-
blasts per well on 12-well plates, performed cell transductions,
cultured the cells with the indicated media, and then monitored
cell contraction. For accurate analyses of the cell count, we used
an all-in-one fluorescence microscope (BZ-9000; Keyence). The
cells were maintained at 37C and 5% CO2 using the controlled
chamber within the microscope. We first acquired images of the
cells in all the areas in a well with a 203 phase contrast lens by
moving themotorized stage sequentially. Next, wemoved the field
to cover all the areas in a well and counted the number of sponta-
neously contracting cells in each field with the 203 phase contrast
lens in at least three independent experiments. We identified the
individual beating iCMs based on differences in beating frequency,
cell-membrane boundary, and nuclei identified by phase contrast
and GFP fluorescence filter. The cardiac reprogramming efficiency
was determined as the number of beating cells per 50,000 starting
fibroblasts. Themeasurements and calculations were conducted in
a blinded manner.Gene Microarray Analyses
Genome-wide gene expression analyses were performed using the
3D-Gene Mouse Oligo Chip 25k (Toray Industries). For efficient
hybridization, this microarray was 3D and constructed with a
well as the space between the probes and cylinder-stems with 70-
mer oligonucleotide probes on the top. RNA was extracted from
neonatal mouse heart tissue, MEFs, TTFs, and MT-, GMT-, or
GMTMM-induced aMHC-GFP+ cells using the ReliaPrep RNA
Cell Miniprep System (Promega, Z6012). Total RNA was labeled
withCy5 by using an Amino AllylMessageAMP II aRNAAmplifica-
tion Kit (Applied Biosystems), and hybridization was performed
using the supplier’s protocols (www.3d-gene.com). Hybridization
signals were scanned using a 3D-Gene Scanner (Toray Industries)
and processed by extraction (Toray Industries). The raw data for
each spotwere normalized by substitutionwith themean intensity
of the background signal determined by the combined signal in-
tensities of all blank spots at 95% confidence intervals. Raw data
intensities greater than 2 SD of the background signal intensity
were considered valid. Signals detected for each gene were normal-
ized by the global normalization method. Heatmap images for
differentially expressed genes (more than 2- or 1.5-fold differences)
were processed using Cluster (v.2.0) software, and the results were
displayed with the TreeView program (http://www.eisenlab.org/
eisen/?page_id=42). Scatter plot analyses were processed using Mi-
crosoft Excel. Gene ontology (GO) analysis was performed using
GeneCodis (Carmona-Saez et al., 2007; Nogales-Cadenas et al.,
2009). This method computes hypergeometric p values for the
over- or underrepresentation of each GO term in the specified
ontology for the gene set of interest. Moderated t-statistics and
the associated p values were calculated by the Welch t test using
Microsoft Excel. Differential gene expression was defined using
the statistics/threshold combination.e Authors
Statistical Analyses
Differences between groups were examined for statistical signifi-
cance using the Student’s t tests or ANOVA. Differences with
p values of less than 0.05 were regarded as significant.
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